SE423456B - Method of producing antiserum for histological identification of endocrine-active cells, especially cells producing substance P - Google Patents
Method of producing antiserum for histological identification of endocrine-active cells, especially cells producing substance PInfo
- Publication number
- SE423456B SE423456B SE8006439A SE8006439A SE423456B SE 423456 B SE423456 B SE 423456B SE 8006439 A SE8006439 A SE 8006439A SE 8006439 A SE8006439 A SE 8006439A SE 423456 B SE423456 B SE 423456B
- Authority
- SE
- Sweden
- Prior art keywords
- antiserum
- cells
- producing
- granule fraction
- peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
10 20 ' gzs 30 35 40 n' 5 sooe4à9-7 ledningsvis angivna sättet enligt uppfinningen erhallit de ckännetecken, som framgår av patentkravet 1. 10 20 'gzs 30 35 40 n ' 5 sooe4à9-7 the method according to the invention according to the invention characteristics as claimed in claim 1.
",Särskilt avses att genom sättet enligt uppfinningen isolera en peptid- eller proteinkomponent från sådana endo- -krint aktiva celler, som tidigare inte har kunnat identifie- ras genom tillämpning av-gängse teknik, och att.framställa antisera mot denna komponent, vilka sedan kan appliceras på mikroskopiska histologiska snitt för pâvisande av dessa cel- lers förekomst i snittet. I , '_ Uppfinningen ekemplifieras i det följande genom beskriv- ning av sättets tillämpning på vissa endokrint aktiva celler i mag-tarmkanalen tillhörande det s k enterokromaffina cell- systemet. W e 0 0 _ Eftersom peptidhormon-producerande celler i mag-tarmkana~ len ej förekommer samlade utan är diffust utspridda, möter det stora svårigheter att isolera enstaka peptider från sådana celler, Vid den som exempel valda tillämpningen har därför i stället valts möjligheten att isolera de ifrågavarande cell- komponenterna ur en tumör, utgången från celler av den tumör- ggrupp, som betecknas som substans P-producerande carcinoid.In particular, it is intended that by the method according to the invention isolate a peptide or protein component from such endocytes -cryptally active cells, which have not previously been able to identify race through the application of current technology, and to produce antisera against this component, which can then be applied to microscopic histological sections to detect these cells occur in the section. I, '_ The invention is exemplified in the following by describing application of the method to certain endocrine active cells in the gastrointestinal tract belonging to the so-called enterochromaffin cell the system. W e 0 0 _ Because peptide hormone-producing cells in the gastrointestinal tract ~ len does not appear collected but is diffusely scattered, meets the great difficulty in isolating individual peptides from such cells, In the example selected application has therefore in instead, the possibility of isolating the cells in question components of a tumor, the output of cells of the tumor group, which is designated as substance P-producing carcinoid.
, Tumörcellerna disintegreradesgenom homogenisering i 0,3 M csukroslösning, och det erhållna homogenisatet rensades från celler, cellkärnor och andra större fragment genom centrifu- gering vid 1000 xlg i 20 minuter vid 0°C. Supernatanten fick passera en serie MHLIPOR-filter'med avtagande porstorlek: 8000, 5000, 3000, l200 och 800 nm. Filtratet, en olöslig frak- tion med partikelstorleken mindre än 800 nm centrifugerades därefter vid 40000 x g i 30 minuter. Det därigenom erhållna sedimentet eller pelleten slammades upp i destillerat vatten, g dialyserades mot vatten under något dygn och lyofiliserades.The tumor cells were disintegrated by homogenization in 0.3 M sucrose solution, and the resulting homogenate was purified cells, cell nuclei and other larger fragments by centrifugation fermentation at 1000 xlg for 20 minutes at 0 ° C. The supernatant received pass a series of MHLIPOR filters with decreasing pore size: 8000, 5000, 3000, l200 and 800 nm. The filtrate, an insoluble fraction particle size less than 800 nm was centrifuged then at 40,000 x g for 30 minutes. It thereby obtained the sediment or pellet was slurried in distilled water, g was dialyzed against water for a few days and lyophilized.
Det lyofiliserade materialet suspenderades därefter i en vattenlösning och homogeniserades, varigenom erhölls en sus- pension, bestående av såväl lösliga som olösliga komponenter i granulas väggar och innehåll. Ett antal kaniner immunisera- des genom intrakutan injektion av suspensionen tillsamman med s k Freunds adjuvans. Efter sex veckor kunde antikroppar mot någon komponent i suspensionen påvisas genom att tumörceller från substans P-producerande carcinoider reagerade vid kon- ventionell immunohistokemisk färgning., ' pDet antigen, som vid det beskrivna tillvägagângssättet 10 8006439-7 ger upphov ti11 antikropparna i erhâiïet antiserum, har ännu inte kunnat bestämt identifieras.The lyophilized material was then suspended in one aqueous solution and homogenized to give a suspension pension, consisting of both soluble and insoluble components in granule walls and contents. A number of rabbits immunize by intracutaneous injection of the suspension together with s k Freund's adjuvant. After six weeks, antibodies against any component of the suspension is detected by tumor cells from substance P-producing carcinoids reacted at con- conventional immunohistochemical staining. The antigen, as in the described procedure 10 8006439-7 gives rise to the antibodies in the obtained antiserum, has yet could not be definitively identified.
Vid appïicering av antiserumet på histoïogiska snitt från normal mag-tarmkanai har man funnit, att antikropparna kan bindas tiil de endokrint aktiva ceiïer, från viïka substans P-producerande carcinoider anses utgå. En serie carcinoidtumö- rer har undersökts med PAP-färgat antiserum, framstäïit eniigt ovan, och man har då funnit, att sådana tumörer visar en po- sitiv reaktion med antiserumet. Däremot reagerar detta inte med ce11er från tumörer av annat ursprung.When applying the antiserum to histological sections from normal gastrointestinal tract it has been found, that the antibodies can be bound to the endocrine active cells, from viika substance P-producing carcinoids are considered deleted. A series of carcinoid tumors have been tested with PAP-stained antiserum, presented unanimously above, and it has then been found that such tumors show a positive positive reaction with the antiserum. However, this does not react with ce11s from tumors of other origin.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8006439A SE423456B (en) | 1980-09-15 | 1980-09-15 | Method of producing antiserum for histological identification of endocrine-active cells, especially cells producing substance P |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8006439A SE423456B (en) | 1980-09-15 | 1980-09-15 | Method of producing antiserum for histological identification of endocrine-active cells, especially cells producing substance P |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8006439L SE8006439L (en) | 1982-03-16 |
SE423456B true SE423456B (en) | 1982-05-03 |
Family
ID=20341732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8006439A SE423456B (en) | 1980-09-15 | 1980-09-15 | Method of producing antiserum for histological identification of endocrine-active cells, especially cells producing substance P |
Country Status (1)
Country | Link |
---|---|
SE (1) | SE423456B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983003307A1 (en) * | 1982-03-15 | 1983-09-29 | Hakansson, Rolf | Method for production of antiserum against granula fraction from endocrinologically active cells |
-
1980
- 1980-09-15 SE SE8006439A patent/SE423456B/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983003307A1 (en) * | 1982-03-15 | 1983-09-29 | Hakansson, Rolf | Method for production of antiserum against granula fraction from endocrinologically active cells |
Also Published As
Publication number | Publication date |
---|---|
SE8006439L (en) | 1982-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Takeuchi | Immunochemical and immunohistochemical studies on the development of the cellular slime mold Dictyostelium mucoroides | |
De Camilli et al. | Synapsin I (Protein I), a nerve terminal-specific phosphoprotein. II. Its specific association with synaptic vesicles demonstrated by immunocytochemistry in agarose-embedded synaptosomes. | |
Greaves et al. | Effect of bursectomy and thymectomy on the responses of chicken peripheral blood lymphocytes to phytohaemagglutinin | |
Slot et al. | Platelet factor VIII-related antigen: immunofluorescent localization | |
Mills et al. | Excretions and secretions of Trichinella spiralis and their role in immunity | |
CN107243012A (en) | A kind of applications of the 5p of miR 93 that exosomes is loaded in treatment rheumatoid arthritis | |
CN116333987A (en) | Application of NK cell exosomes obtained by exosome extraction method in resisting tumor | |
Hollinshead et al. | Reactivity between herpesvirus type 2-related soluble cervical tumor cell membrane antigens and matched cancer and control sera | |
Meyer et al. | Cerebriform (Sézary like) mononuclear cells in healthy individuals: a morphologically distinct population of T cells: relationship with mycosis fungoides and Sézary’s syndrome | |
Grisley et al. | Recognition of food in Octopus digestive tract | |
Claflin et al. | The Dunning R3327 prostate adenocarcinoma in the Fischer-Copenhagen F1 rat: a useful model for immunological studies | |
Price et al. | Preparation of aminoazo dye induced rat hepatoma membrane fractions retaining tumour specific antigen | |
SE423456B (en) | Method of producing antiserum for histological identification of endocrine-active cells, especially cells producing substance P | |
CN110548138B (en) | Aptamer modified alpha-Gal liposome and preparation method and application thereof | |
Wardley et al. | Lymphocvte responses to African swine fever virus infection | |
CN106754692B (en) | Erythrocyte membrane and preparation method and application thereof | |
US4888275A (en) | Diagnosing and monitoring cancer | |
Kaiserling et al. | IgM-producing malignant lymphomas without macroglobulinemia. Morphological and immunochemical findings | |
KR102021176B1 (en) | Monoclonal antibody and inspection Kit. | |
EP1935903A1 (en) | A method for preserving human cell membrane antigen and human cell membrane antigen coated with magnetic particle | |
de Palozzo et al. | Immunoelectrophoretic studies with bean proteins | |
Volsky et al. | Implantation of mouse histocompatibility antigens into membranes of cultured tumor cells | |
Diggs | Immunodiffusion studies of Plasmodium berghei: interactions of an extract of the erythrocytic forms with rabbit antisera | |
Tamura et al. | Regulatory Mechanism of Delayed‐Type Hypersensitivity in Mice: III. In Vitro Analysis of Memory T Cells Involved in Augmentation of DTH Responses | |
Palm et al. | Immunogenetic analysis of microsomal and non‐microsomal lipoproteins from normal and malignannt mouse tissues for histocompatibility‐2 (H‐2) antigens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8006439-7 Effective date: 19920408 Format of ref document f/p: F |